Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Brain and Nerve = Shinkei Kenkyu No Shinpo|March 10, 2026
[Potential of Blood Biomarkers for Early Diagnosis of Dementia]Kenji Tagai, Takahiko TokudaPsychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|January 14, 2020
Anosognosia in patients with Alzheimer's disease: current perspectivesKenji Tagai, Tomoyuki Nagata, Shunichiro Shinagawa, et al.International Psychogeriatrics|December 1, 2012
A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson diseaseTomoyuki Nagata, Shunichiro Shinagawa, Kenji Tagai, et al.Nature Reviews. Neurology|August 12, 2025
Advances in PET imaging of protein aggregates associated with neurodegenerative diseaseMakoto Higuchi, Kenji Tagai, Keisuke Takahata, et al.Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|February 7, 2018
Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensationKenji Tagai, Shunichiro Shinagawa, Hidehiro Kada, et al.Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|August 6, 2013
Mirtazapine improves visual hallucinations in Parkinson's disease: a case reportKenji Tagai, Tomoyuki Nagata, Shunichiro Shinagawa, et al.Aging & Mental Health|May 31, 2014
Correlation between cognition and symptomatic severity in patients with late-life somatoform disordersKeisuke Inamura, Norifumi Tsuno, Shunichiro Shinagawa, et al.Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|February 19, 2022
Education level is associated with neuropsychiatric symptoms in patients with amnestic-mild cognitive impairmentKeisuke Inamura, Shunichiro Shinagawa, Tomoyuki Nagata, et al.Psychosomatics|January 18, 2015
Cognitive Dysfunction in Patients With Late-Life Somatic Symptom Disorder: A Comparison According to Disease SeverityKeisuke Inamura, Shunichiro Shinagawa, Tomoyuki Nagata, et al.Psychosomatics|April 6, 2016
Executive Dysfunction Correlated With 2-Year Treatment Response in Patients With Late-Life Undifferentiated Somatoform DisordersKeisuke Inamura, Shunichiro Shinagawa, Tomoyuki Nagata, et al.Pageof 7